5 AMA PRA Category 1 Credits™

AMS – 2019FMp2-Family Medicine – Pharmacology: New Drugs; Oral Anticoagulants; Antimicrobial Resistance

$119.00$189.00

$119.00
$189.00
StreamingINCLUDED FREE

Topics and Objectives

Title: Family Medicine – Pharmacology: New Drugs; Anticoagulants – Oral; Antimicrobial Resistance

Faculty: Vandana Y. Bhide, M.D., F.A.C.P., F.A.A.P., A.B.I.H.M, Keith S. Kaye, M.D., M.P.H., Gerald W. Smetana, M.D.

Original Release Date: July 1, 2019  Expiration Date: July 1, 2022

TOPIC 1: New Drugs for the Primary Care Physician: What You Need to Know.      

Upon completion of this session, the participant should be able to: COMP

  1. Survey important advances in pharmacotherapy that pertain to primary care practice.
  2. Discuss the efficacy and list the side effects for each drug.
  3. Differentiate key new drugs with previously available medications for similar indications.

TOPIC 2: Novel Oral Anticoagulants.

Upon completion of this session, the participant should be able to:COMP, EBM

  1. Differentiate the advantages and disadvantages of commonly used anticoagulants.
  2. Employ evidence-based anticoagulation bridging regimens.
  3. Assess the approved indications for various anticoagulation agents.
  4. Apply the evidence-based indications for anticoagulation in hospitalized patients.

TOPIC 3: Update on Antimicrobial Resistance.

Upon completion of this session, using IDSA and SHEA evidence-based guidelines and CDC and WHO surveys, the participant should be able to: COMP, GL, EBM

    1. Interpret the pattern of emergence of resistance of certain infecting bacteria.
    2. Analyze the epidemiology that may indicate potential resistance among the organisms discussed, such as:
      1. Pneumococci;
      2. Enterococci;
      3. Gram negative bacilli.
    3. Use current therapeutic regimens while considering resistance.


Total Cost: $

Title: Family Medicine – Pharmacology: New Drugs; Anticoagulants – Oral; Antimicrobial Resistance

Faculty: Vandana Y. Bhide, M.D., F.A.C.P., F.A.A.P., A.B.I.H.M, Keith S. Kaye, M.D., M.P.H., Gerald W. Smetana, M.D.

Original Release Date: July 1, 2019  Expiration Date: July 1, 2022

TOPIC 1: New Drugs for the Primary Care Physician: What You Need to Know.      

Upon completion of this session, the participant should be able to: COMP

  1. Survey important advances in pharmacotherapy that pertain to primary care practice.
  2. Discuss the efficacy and list the side effects for each drug.
  3. Differentiate key new drugs with previously available medications for similar indications.

TOPIC 2: Novel Oral Anticoagulants.

Upon completion of this session, the participant should be able to:COMP, EBM

  1. Differentiate the advantages and disadvantages of commonly used anticoagulants.
  2. Employ evidence-based anticoagulation bridging regimens.
  3. Assess the approved indications for various anticoagulation agents.
  4. Apply the evidence-based indications for anticoagulation in hospitalized patients.

TOPIC 3: Update on Antimicrobial Resistance.

Upon completion of this session, using IDSA and SHEA evidence-based guidelines and CDC and WHO surveys, the participant should be able to: COMP, GL, EBM

    1. Interpret the pattern of emergence of resistance of certain infecting bacteria.
    2. Analyze the epidemiology that may indicate potential resistance among the organisms discussed, such as:
      1. Pneumococci;
      2. Enterococci;
      3. Gram negative bacilli.
    3. Use current therapeutic regimens while considering resistance.

Additional information

Format

Hardcopy, Download

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.